These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19530745)

  • 21. Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).
    Wu T; Shi Y; Zhu B; Li D; Li Z; Zhao Z; Zhang Y
    Expert Opin Drug Saf; 2024 Mar; 23(3):313-321. PubMed ID: 37612600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
    Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
    Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
    Fujimoto M; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
    di Mauro G; Zinzi A; Scavone C; Mascolo A; Gaio M; Sportiello L; Ferrajolo C; Rafaniello C; Rossi F; Capuano A
    Drug Saf; 2021 Mar; 44(3):337-349. PubMed ID: 33351170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do lipid-lowering drugs cause erectile dysfunction? A systematic review.
    Rizvi K; Hampson JP; Harvey JN
    Fam Pract; 2002 Feb; 19(1):95-8. PubMed ID: 11818357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of ADRs associated with lipid-lowering agents recorded in the Department of Internal Medicine, University Hospital, Jena.
    Hippius M; Farker K; Helble S; Hoffmann A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):97-101. PubMed ID: 11911604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statins on blood pressure: Analysis on adverse events released by FDA.
    You T; Liu XG; Hou XD; Wang XK; Xie HH; Ding F; Yi K; Zhang P; Xie XD
    Clin Exp Hypertens; 2017; 39(4):325-329. PubMed ID: 28513233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin use and incident erectile dysfunction--A nationwide propensity-matched cohort study in Taiwan.
    Chou CY; Yang YF; Chou YJ; Hu HY; Huang N
    Int J Cardiol; 2016 Jan; 202():883-8. PubMed ID: 26476986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea.
    Kim H; Kim N; Lee DH; Kim HS
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):409-413. PubMed ID: 28500776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
    van Hunsel F; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):26-32. PubMed ID: 19953500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study.
    Despas F; Rousseau V; Lafaurie M; De Canecaude C; Durrieu G; Bagheri H; Montastruc F; Montastruc JL
    Fundam Clin Pharmacol; 2019 Dec; 33(6):695-702. PubMed ID: 31251421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase.
    Essers D; Schäublin M; Kullak-Ublick GA; Weiler S
    Eur J Clin Pharmacol; 2019 Mar; 75(3):409-416. PubMed ID: 30430215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy.
    Motola D; Vargiu A; Leone R; Conforti A; Moretti U; Vaccheri A; Velo G; Montanaro N
    Drug Saf; 2008; 31(7):609-16. PubMed ID: 18558794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?
    Sommet A; Grolleau S; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Eur J Clin Pharmacol; 2008 Aug; 64(8):829-34. PubMed ID: 18509626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature.
    Roberto G; Biagi C; Montanaro N; Koci A; Moretti U; Motola D
    Eur J Clin Pharmacol; 2012 Jun; 68(6):1007-11. PubMed ID: 22286160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
    Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B
    Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.